Accelerating Peptide Development: Strategies to optimize the formulation and manufacture of peptide therapeuticsRegister here
Enhance your clinical development program with our modeling and simulation services. Quotient Sciences’ experts’ help you pinpoint the question you need to answer and identify the data you need to collect.
Our Modeling and Simulation (M&S) team possess vast experience performing physiologically based pharmacokinetic (PBPK) modeling. We can provide a mechanistic understanding of the likely performance and disposition of your drug product (generic or NCE) in vivo and inform risk-based decisions on formulation and clinical design, ultimately reducing the cost of development.
The valuable role of M&S in drug development programs is being acknowledged through increasing inclusion in global regulatory submissions. We work collaboratively with you and can provide long-term support to your development programs, from drug discovery to life-cycle management.
Our modeling and simulation activities span early clinical development through to life cycle management and are tailored to answer your specific needs. We offer services in either a standalone capacity or integrated with a clinical study conducted at Quotient.